Corrigendum to " In vitro antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids" [Heliyon Volume 10, Issue 19, October 2024, Article e38434]
- PMID: 39759860
- PMCID: PMC11700663
- DOI: 10.1016/j.heliyon.2024.e40195
Corrigendum to " In vitro antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids" [Heliyon Volume 10, Issue 19, October 2024, Article e38434]
Abstract
[This corrects the article DOI: 10.1016/j.heliyon.2024.e38434.].
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Erratum for
-
In vitro antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids.Heliyon. 2024 Sep 28;10(19):e38434. doi: 10.1016/j.heliyon.2024.e38434. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397937 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources